Kerry Chester

6.6k citations

125 papers · 4.5k indexed · h-index 42

Impact in

Radiology, Nuclear Medicine and Imaging top 0.5%
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
Oncology top 1%
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research

Papers in

Radiology, Nuclear Medicine and Imaging 84
- Monoclonal and Polyclonal Antibodies Research 82
- Radiopharmaceutical Chemistry and Applications 20
Oncology 48
- CAR-T cell therapy research 23
- HER2/EGFR in Cancer Research 14

Co-authors: Richard H. J. Beǵent Robert E. Hawkins Berend Tolner L. Robson Mark E. B. Smith RB Pedley Enrique Miranda Vijay Chudasama
Journals: International Journal of Cancer (6 papers)Bioconjugate Chemistry (5 papers)European Journal of Cancer (4 papers)mAbs (4 papers)Cancer Research (3 papers)
Partner nations: United Kingdom United States India

In The Last Decade

Kerry Chester

122 papers receiving 4.4k citations

Peers

Countries citing papers authored by Kerry Chester

Since Specialization

Citations

This map shows the geographic impact of Kerry Chester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry Chester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry Chester more than expected).

Fields of papers citing papers by Kerry Chester

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerry Chester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry Chester. The network helps show where Kerry Chester may publish in the future.

Co-authors

The 25 scholars most cited alongside Kerry Chester, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kerry Chester Line = papers co-authored together Kerry Chester links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phenoscaping Reveals Multimodal γδ T-cell Cytotoxicity as a Strategy to Overcome Cancer Cell–Mediated Immunomodulation Cancer Research ·Janaína de Sousa Mesquita, Yung- Li Chen, Daniel Fowler, Colin Hutton, Majid Shaikh, Jahangir Sufi, A. Powell Davies, Петрова Елена Ивановна, Claire Naudat, Peter Gemeinhardt, Xiao Qin, Ashley A. Campbell, 雅巳楡井, Vivian Li, Kerry Chester, John Anderson, Marta Barisa, Jonathan Fisher, Christopher J. Tape	2025	0
2	Potent and Effective Targeting of AML with ‘Off-the-Shelf’ Engineered CD45-Targeting CAR T-Cells Blood ·向洪全, Aiyin Liao, Naeem Khan, Sylvie Freeman, Thomas E. Whittaker, Adrian J. Thrasher, Martin Pulé, Kerry Chester, Jenny Yeung, Margit K. Werner	2024	2
3	scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells Journal of Nanobiotechnology ·محمدرضا کریم, Cláudia Martins, Tânia Cruz, Flávia Castro, Ângela M. Costa, Kerry Chester, María José Oliveira, Bruno Sarmento	2023	10
4	A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors Cell Death and Disease ·徐振洋, Leonardo Marques Pereira, Jorge de Oteiza Enbil, Alifia Zahra Khoirunisa, Шыхберди Атаев, Johannes Doerner, Hubert Zirngibl, Maximilian Ackermann, H. M. Kvasnicka, Kerry Chester, Dirk Jäger, Claudia R. Ball, Guy Ungerechts, Christine E. Engeland	2023	5
5	Targeting of low ALK antigen density neuroblastoma using AND logic-gate engineered CAR-T cells Cytotherapy ·Lee Su Young, P. Laba, DECLARE L. MUSHI, Cristian Alejandro Cortés, Marta Barisa, Münster Kleinsasser, Alice Piapi, Preeya Kundasamy, Talia Gileadi, Jenny Yeung, K Mróz, Jonathan Fisher, 林洲富林洲富, Laura Donovan, Louis Chesler, Kerry Chester, John Anderson	2022	13
6	An Antibody-Tumor Necrosis Factor Fusion Protein that Synergizes with Oxaliplatin for Treatment of Colorectal Cancer Molecular Cancer Therapeutics ·Zhi-xiang Yu, Kerry Chester, Dario Neri	2020	8
7	Antibody engineering and therapeutics conference mAbs ·James W. Larrick, Paul W.H.I. Parren, James S. Huston, Andreas Plückthun, Andrew Bradbury, Ian M. Tomlinson, Kerry Chester, Dennis R. Burton, Gregory P. Adams, Louis M. Weiner, Jamie K. Scott, Krzysztof Kowal, F.J. Healy wife, Janice M. Reichert	2014	2
8	Developments in single photon emission computed tomography and PET-based HER2 molecular imaging for breast cancer Expert Review of Anticancer Therapy ·Robert M. Goldstein, Jane Sosabowski, Fatima Koroma, Kerry Chester, Tim Meyer	2013	20
9	Impact of expression system on the function of the C6.5 diabody PET radiotracer Tumor Biology ·Joshua Miller, Mohan Doss, Ryan McQuillen, Calvin Shaller, Berend Tolner, Jian Yu, Kerry Chester, Matthew K. Robinson	2012	6
10	Evidence of efficacy of antibody directed enzyme prodrug therapy (ADEPT) in a Phase I trial in patients with advanced carcinoma. Cancer Research ·RajKumar Nagpal, Astrid Mayer, Surinder K. Sharma, Berend Tolner, Roslyn J. Francis, Caroline J. Springer, 景司山本, G Boxer, James R. Bell, Alan Green, Moey Chen Lim, Violeta González González, M. Calabrese, Sivebaek Ion Marius, Kerry Chester, Richard H. J. Beǵent	2008	2
11	A novel human enzyme with a bis-chloro-phenol prodrug for Antibody Directed Enzyme Prodrug Therapy (ADEPT) UCL Discovery (University College London) ·芳政伊東, Berend Tolner, Heide Kogelberg, Rhj Begent, L Robson, R. Galand, Kerry Chester	2007	2
12	A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P UCL Discovery (University College London) ·E.V. Isaenko, G Camplani, SK Sharma, V I Menitskaia, Moey Chen Lim, Berend Tolner, Violeta González González, Marc Germain, Paul Beckett, Zulewski, Muhammad Richo Arrafi, Kerry Chester, Rhj Begent	2004	5
13	HSAbodies: A new class of engineered antibody-based molecules for targeting cancer Ghent University Academic Bibliography (Ghent University) ·Alexandra Huhalov, Candace Graff, J. P. SEGUIN, Berend Tolner, RB Pedley, Wouter Vervecken, Roland Contreras, Rhj Begent, Kerry Chester	2004	1
14	The effect of ADEPT, as a single or combined therapy, in two colorectal xenografts. UCL Discovery (University College London) ·SK Sharma, Emily Sandrussi, Janice Silva, Diego Salas, Zulewski, M. Lindel, Kerry Chester, Rhj Begent	2003	3
15	Reversible Dimer Formation and Stability of the Anti-tumour Single-chain Fv Antibody MFE-23 by Neutron Scattering, Analytical Ultracentrifugation, and NMR and FT-IR Spectroscopy Journal of Molecular Biology ·prahlad ram arya, Mark K. Boehm, Kerry Chester, Richard H. J. Beǵent, Stephen J. Perkins	2002	31
16	Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer Cancer Chemotherapy and Pharmacology ·Kerry Chester, Astrid Mayer, Jocelyn S. Bodmer, L. Robson, Daniel I. R. Spencer, Muhammad Fahim, Aiden Flynn, Surinder K. Sharma, Zulewski, R. Barbara Pedley, Richard H. J. Beǵent	2000	36
17	A vector for expression of dimeric and chelating forms of anti-CEA scFvS UCL Discovery (University College London) ·(unknown), L. Robson, Sarah E. Perkins, Rhj Begent, Kerry Chester	1999	2
18	Tumour targeting using MFE-23 :: TNF alpha fusion protein. UCL Discovery (University College London) ·Ayman Ekram Fahim, RB Pedley, R Boden, Enrico Pantone, Georg E. Winter, Rhj Begent, Kerry Chester	1999	1
19	Isolation of a panel of human anti-CEA single chain Fv from a large phage display library UCL Discovery (University College London) ·Chip Weems, John McCafferty, (unknown), Robert Waibel, Kerry Chester, (unknown), Deborah Allen	1999	0
20	A MODEL FOR DOSIMETRY IN RADIOIMMUNOTHERAPY UCL Discovery (University College London) ·RB Pedley, R.G. Dale, A. Dovbnya, (unknown), 정효영, Kerry Chester	1985	2

About Kerry Chester

Kerry Chester is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Biotechnology, Molecular Biology and Immunology, having authored 125 papers that have together received 4.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (82 papers), Glycosylation and Glycoproteins Research (32 papers), CAR-T cell therapy research (23 papers), Radiopharmaceutical Chemistry and Applications (20 papers), Protein purification and stability (14 papers), HER2/EGFR in Cancer Research (14 papers), Virus-based gene therapy research (10 papers) and Cancer Research and Treatments (9 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.1k citations), Oncology (1.9k citations), Immunology (735 citations), Biotechnology (297 citations) and Molecular Biology (2.3k citations). Kerry Chester has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Richard H. J. Beǵent, Robert E. Hawkins, Berend Tolner, L. Robson, Mark E. B. Smith, RB Pedley, Enrique Miranda, Vijay Chudasama, Stephen Caddick and Antoine Maruani. Their work appears in journals such as International Journal of Cancer, Bioconjugate Chemistry, European Journal of Cancer, mAbs and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact